Company profile
Cencora, Inc.
NYSE: COR · Healthcare · Medical - Distribution
#4 of 1,418 Healthcare companies by revenue55th-percentile growth
EA Score
84B+FH 81DQ 91GM 70SS 96
v0.1 · 65/100 weight · provisional
↑ disclosure history, growth stability · ↓ revenue growth (YoY), 3-yr revenue growth
Methodology →Revenue TTM
$328.7B
Rev growth YoY (TTM)
+5.9%
Net income (FY)
$1.6B
Employees
51,000
as of 2026-08-04
Market cap
$60.0B
as of 2026-08-04
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$321.3B$321.3B2025
Net income$1.6B$1.6B2025
Operating income$2.6B$2.6B2025
Total assets$76.6B$76.6B2025
Equity$1.5B$1.5B2025
Revenue trend
FY2020 – FY2025 · USD
FY20
FY20
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Pharmaceutical Distribution89%
International Healthcare Solutions9%
Animal Health2%
By geography
U.S. Healthcare Solutions91%
International Healthcare Solutions9%
The read
What is Cencora, Inc.’s revenue?
Cencora, Inc. booked $321.3B in FY2025 revenue, growing 9.3% year over year — about the middle of the pack among Healthcare companies we track, at a 0.5% net margin.
Peers · Healthcare
UnitedHealth Group Incorporated80B+McKesson Corporation85ACVS Health Corp.83B+Cigna Corporation77B+Cardinal Health, Inc.84B+Elevance Health Inc.85ANeighbors
Montgomery →Key facts
CEORobert Mauch
SectorHealthcare
IndustryMedical - Distribution
HeadquartersConshohocken, PA
ExchangeNYSE: COR
Employees51,000
IPO date1995-04-04
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.